GENE ONLINE|News &
Opinion
Blog

2017-12-31|

December 31, 2015: Researchers First Used CRISPR to Treat a Genetic Disease in Mice

by GeneOnline
Share To

Researchers at the Duke University used CRISPR technology to treat Duchenne Muscular Dystrophy (DMD), and published the report on December 31, 2015 on Science journal. DMD is a genetic disease that can also occur in humans. This was the first case in which CRISPR technology is used to treat inherited diseases in adult mammals and was of great importance to the development of human gene therapy.

Reference
http://www.sciencemag.org/news/2015/12/crispr-helps-heal-mice-muscular-dystrophy

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Sarepta Submits BLA for First-Ever Duchenne Muscular Dystrophy Gene Therapy
2022-10-03
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Verve Starts Human Trials for Gene Editing Medicine, Targeting Heterozygous Familial Hypercholesterolemia
2022-07-19
LATEST
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01
FDA Revokes Authorization Of Eli Lilly’s COVID-19 Antibody
2022-12-01
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!